[{"AccountsPayableCurrent_0_Q1_USD":100703000.0,"ContractWithCustomerLiability_0_Q1_USD":76300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":481283000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":178100000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":2199419000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q1_USD":51460000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":116900000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":136167000.0,"MarketableSecuritiesCurrent_0_Q1_USD":596984000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":181745000.0,"ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_0_Q1_shares":5519000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":115706000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":400000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-6651000.0,"OtherLiabilitiesCurrent_0_Q1_USD":179776000.0,"InterestIncomeExpenseNet_1_Q1_USD":-14136000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":3601964000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":2157586000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":41833000.0,"ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_1_Q1_USD":6990000.0,"ProceedsFromSaleAndMaturityOfOtherInvestments_1_Q1_USD":72036000.0,"OciBeforeReclassificationsNetOfTaxAttributableToParent_1_Q1_USD":22346000.0,"IncreaseDecreaseInOtherDeferredLiability_1_Q1_USD":36705000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":44825000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":532952000.0,"EarningsPerShareDiluted_1_Q1_USD":2.29,"StockRepurchasedDuringPeriodValue_1_Q1_USD":300026000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":60145000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":26821000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q1_USD":1194000.0,"EquitySecuritiesFvNi_0_Q1_USD":165178000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_1_Q1_USD":77594000.0,"SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_0_Q1_USD":137.34,"ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_0_Q1_shares":3203000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q1_USD":115706000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1515107000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":79597000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":5800000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":75265000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":136167000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-9668000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_1_Q1_USD":-5000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_1_Q1_USD":18782000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q1_USD":64246000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-2662000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"InvestmentIncomeInterestAndDividend_1_Q1_USD":12576000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":117427000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":24835000.0,"IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements_1_Q1_shares":31000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":153814000.0,"ImpairmentOfInvestments_1_Q1_USD":0.0,"FinanceLeasePrincipalPayments_1_Q1_USD":10287000.0,"EquitySecuritiesFvNiUnrealizedLoss_1_Q1_USD":0.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":-44870000.0,"EquitySecuritiesFvNiUnrealizedGain_1_Q1_USD":78082000.0,"EquitySecuritiesFvNiCost_0_Q1_USD":87096000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-764000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":1147705000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":657534000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":15356000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":1258271000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1250225000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":736303000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":223648000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":19450000.0,"NetIncomeLoss_1_Q1_USD":602753000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":815698000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":31666000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-359430000.0,"LiabilitiesCurrent_0_Q1_USD":1538750000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":8893201000.0,"Liabilities_0_Q1_USD":2431547000.0,"CommitmentsAndContingencies_0_Q1_USD":0.0,"InventoryNet_0_Q1_USD":187087000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":223672000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":14285000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":54781000.0,"CostsAndExpenses_1_Q1_USD":794883000.0,"CommonStockValue_0_Q1_USD":2591000.0,"CommonStockSharesOutstanding_0_Q1_shares":259079000.0,"CommonStockSharesIssued_0_Q1_shares":259079000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":3593412000.0,"AssetsCurrent_0_Q1_USD":5446400000.0,"Assets_0_Q1_USD":8893201000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":13383000.0,"AccountsReceivableNetCurrent_0_Q1_USD":845269000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-2790000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"IncomeTaxesPaidNet_1_Q1_USD":5845000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":618109000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":7695905000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":259815000.0,"OtherAssetsNoncurrent_0_Q1_USD":160635000.0,"Goodwill_0_Q1_USD":1002158000.0,"EarningsPerShareBasic_1_Q1_USD":2.32,"CostOfGoodsAndServicesSold_1_Q1_USD":162497000.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":178100000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":1600000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":6461654000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-61130000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":57808000.0,"IncreaseDecreaseInInventories_1_Q1_USD":27450000.0,"Cash_0_Q1_USD":1800000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":263515000.0,"SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_0_Q1_USD":119.05,"ShareBasedCompensation_1_Q1_USD":115706000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":182258000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":448528000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":300026000.0,"OperatingIncomeLoss_1_Q1_USD":720224000.0,"InterestPaidNet_1_Q1_USD":13771000.0,"UnrealizedGainLossOnInvestments_1_Q1_USD":-39400000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":43000000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20200501"}]